Live Forever Club’s Post

AlphaProteo: Google DeepMind unveils protein design system - https://lnkd.in/g3thq6nN Google DeepMind has unveiled an AI system called AlphaProteo that can design novel proteins that successfully bind to target molecules, potentially revolutionising drug design and disease research. ..... #AINews #Google #DeepMind #AlphaProteo

Innovation in action: Learn how explainable AI is revolutionizing the fight against antibiotic-resistant bacteria like MRSA. Read more about this groundbreaking discovery. #planetpharma #lifesciences

Our immune system is implicated in every health condition. If we want to improve the drug development process, we must first start by studying this incredibly complex system. I spoke with Jim Cornall on Beyond Biotech Podcast about just that: harnessing the power of AI for a deeper understanding of the immune system. By mapping the immune system with AMICA, the world’s largest single-cell immune database, Immunai is redefining drug development. Listen to the full podcast to hear more about our approach to precise and personalized medicine #ImmuneSystem #DrugDevelopment #AI #PersonalizedMedicine #BiotechInnovation

DigiHealth is a convergence of AI’s prowess with the intricacies of healthcare and pharmaceuticals. It’s a showcase of how genetic research is being redefined by AI, the transformation of healthcare businesses through intelligent systems, and the advancements in drug development and diagnostics powered by data analytics. Explore these four topics with us: 🩺 AI in Diagnostics & Medical Imaging 🧬 Gene Research with AI 📈 Healthcare Business Transformation 💊 Drug and Clinical Research Analytics   Transform healthcare & pharma with AI! Tickets are available! 📅 Nov 21st - 22nd | 📍 Belgrade | 🏟️ Metropol Palace Hotel Tickets 🎟➡ https://digihealth.ai/ To learn more about our upcoming conference click here: https://lnkd.in/gpnZtcE  #ai #datascience #ml #healthcare #clinicaltrial #drugtrial #AIinHealthcare #generesearch #genes #medical #MedicalImaging #diagnostics #digihealth #dsceurope #belgrade #serbia

Navigating the Tides of Innovation: FDA Approval and Quality Assurance 🌊🔬 In 2024, the FDA's nod to two pioneering treatments has been nothing short of revolutionary for healthcare. As we reflect on this monumental stride, we must credit the unsung hero behind the scenes: Quality Assurance (QA). 🔍 First, let's talk about the groundbreaking gene therapy that's giving hope to millions battling neurodegenerative diseases. The precision and specificity of this treatment are astounding – it's like sending a GPS-guided molecular messenger to repair genetic errors directly at their source. And the second marvel? A cutting-edge, minimally invasive cardiac device, redefining what we thought was possible in heart repair. But how did QA help catapult these treatments from lab dreams to life-altering realities? Thanks to meticulous QA processes, each phase, from discovery through clinical trials, adhered to the highest standards. It's this rigor that ensures treatments are not only effective but safe. Quality Assurance is our guardian, constantly whispering the questions: Is this product consistent? Is it reliable? Is it safe? Thanks to QA's stringent protocols, integrated from East Coast biotech hubs to Silicon Valley's tech nests, we've dodged countless potential setbacks, bringing these treatments to those in need faster. Both treatments emerged from the confluence of dedicated research and relentless QA – a synergy powered by data integrity and a commitment to excellence that doesn't just meet expectations but exceeds them. 💡 Today, we stand at the precipice of a new health frontier, and it's clearer than ever: Quality Assurance isn't just a checkpoint; it's the backbone of medical innovation. #HealthcareInnovation #FDAApproval #QualityAssurance

In The Kable last week, Nvidia revealed how it is revolutionising drug discovery with its AI technologies, leveraging its BioNeMo toolkits to interpret DNA, RNA, and proteins much like ChatGPT understands English. This innovative approach enables virtual experiments, speeding up research and reducing lab time. Through its AWS HealthOmics platform, featuring tools like DNABERT and EquiDock, Nvidia promises deeper insights into genetics and protein interactions. Read more in The Kable for free. #drugdiscovery #generativeai #healthtech #innovation #thekable #lifesciences

MIND BLOWN!!! AI predicts nearly 1million new antibiotics The details: · Researchers used AI to analyse publicly available data on over 100,000 different genomes and meta-genomes. · The AI then predicted which parts of the microbial genomes could potentially produce antibiotic compounds, generating a list of nearly one million candidates. · 100 of the AI-predicted drug candidates were tested in the lab, with 79 of them being a potential antibiotic. · The paper’s author Cesar de la Fuente said the findings are “the largest antibiotic discovery ever”, accelerating the process from years to just hours. Why it matters: As the world faces growing threats from antibiotic-resistant bacteria, AI’s ability to unlock millions of new potential treatments could be a lifeline toward staying ahead in the race to outsmart superbugs responsible for millions of deaths every year.

The use of AI in detecting antibiotic-resistant bacteria is a game-changer in healthcare. AI can significantly reduce diagnosis time, leading to more targeted treatment strategies. The potential applications of AI technology in healthcare and pharmaceutical industries are vast, with rapid and accurate diagnosis being a key benefit. As drug-resistant bacteria pose a serious global health threat, AI-powered tools can help doctors diagnose illnesses more quickly and accurately. The development of AI systems for detecting various diseases, including Alzheimer's and COVID-19, showcases the transformative power of technology in healthcare. #AI #healthcare #diagnostics #drugdevelopment

Purpose-built AI for drug discovery has exploded in the last 12-18 months. 2023 alone saw 70+ notable LLMs across scientific, protein, genomic, and molecular domains. EvolutionaryScale's ESM3 model, announced earlier this week, is yet another groundbreaking technology that will transform the pace of discovery. In an industry where nothing changes overnight, change is now coming faster than we expect. AI is fundamentally altering the way drugs are designed. But if we fail to reimagine our R&D system to handle the new speed and scale of AI-driven discovery, the industry risks over-promising and under-delivering to the patients who need new medicines the most. We need to apply AI not just in discovery but across the entire R&D lifecycle. Sajith and I wrote about this in STAT: https://lnkd.in/g8g59eHX

NEXT BIG WEBINAR It's about time It's another time to learn and be taught, tell someone to tell someone. It's going to be very elightning 🔔🔔 _The 10th Session_ Topic 1: Charting a Purposeful Career Journey: Aligning Passion with Professional Success Speaker: Tolu Obatunde Topic 2: Revolutionizing Drug Discovery with Artificial Intelligence in Designing Novel Therapeutics Speaker: Adelegan Deborah 🗓️ Date: 17th July,2024 ⏰ Time: 3:00pm GMT. Live session link: https://lnkd.in/e5UwN9F7 I know you don't want to be left out. Thanks. #GenomacInstitute #GenomacHoldings #bioinformatics #Genomics #Webinarseries #Drugdiscovery #Professionaltips #AI